Global Point-of-Care Glucose Testing Market : Industry Analysis And Forecast (2020-2026)

>

Global Point-of-Care Glucose Testing Market : Industry Analysis and Forecast (2020-2026)

Global Point-of-Care Glucose Testing Market is expected to reach $xx Mn in 2026 from $xx Mn in 2019, at a CAGR of xx% during forecast period.
Global Point-of-Care Glucose Testing Market Overview

Point-of-care testing (POCT) for glucose is used to monitor patients with diabetes at the bedside or in the home or hospital. It is typically performed by non-laboratory personnel and the results are used for clinical decision making. The implementation of point-of-care testing (POCT) is to decrease the turnaround time and improve patient care.

Global Point-of-Care Glucose Testing Market

To Know About The Research Methodology :- Request Free Sample Report
Global Point-of-Care Glucose Testing Market Dynamics

Prevalence of diabetes globally is boosting the market growth

Rising diabetes prevalence in low and middle income economies and effects associated with it like blindness, kidney failure, heart attacks and lower limb amputation, are the major factors driving the market. The global prevalence of diabetes in 2019 was 9.3% and it is estimated to rise up to 10.2% by the year 2030.The prevalence is higher in urban (10.8%) than rural (7.2%) areas, and in high-income (10.4%) than low-income countries (4.0%). According to the report published by Center for Disease Control and Prevention (CDC), the type-2 diabetes accounted for 90-95% of all the diabetes cases in US. Technological advancements which provide early, safe and accurate results are stimulating the market growth.Convenience and affordability of glucose monitoring over conventional monitoring,greater awareness and availability of glucose monitors across the globe contribute to the market growth. For instance, Accu-Chek Inform II accounted for the largest revenue share in 2018 and is anticipated to maintain this trend throughout the forecast period. Despite having these advantages, sometimes these tests offer false negative or false positive results, which may impact negatively on the market growth.

The report has profiled key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and the report has come up with recommendations for a future hot spot in the APAC region.
Global Point-of-Care Glucose Testing Market: Segment Analysis

The Global Point-of-Care Glucose Testing Market is segmented based on the product type, testing type and end-users.

Based on the Product Type, the meters segment held dominant market share in 2019. Glucose meters are universally utilized in the management of hypoglycemic and hyperglycemic disorders in a variety of healthcare settings.Glucose meters can only analyze whole blood, and glucose is unstable in whole blood. To determine blood glucose, the measuring beam of infrared light has to penetrate the tissue for measurement of blood glucose.There are currently three CGMS (continuous glucose monitoring system) available. The first is Medtronic's Minimed Paradigm RTS with a sub-cutaneous probe attached to a small transmitter (roughly the size of a quarter) that sends interstitial glucose levels to a small pager sized receiver every five minutes. The Dexcom System is another system, available in two different generations in the US, the G4 and the G5.

Based on Testing Site, the fingertip testing site segment is projected to hold dominant share during the forecast period. This technique is the traditional way of monitoring blood glucose level and its ease of usage factor add up to the market growth. Products like Accu-Chek by Roche Diabetes Care, can be used for both alternate sites testing and fingertip testing.Global Point-of-Care Glucose Testing Market1

Global Point-of-Care Glucose Testing Market1
Global Point-of-Care Glucose Testing Market Regional Insights

Global Point-of-Care Glucose Testing Market2

North America is expected to dominate the global market throughout the forecast period.

Changing lifestyle and inclination towards unhealthy eating habits, smoking, alcohol consumption results in prevalence of diabetes and other lifestyle disorders in the region. Approximately, 34.2 million Americans i.e. 1 in 10 have diabetes. More people are developing type 1 and type 2 diabetes during youth, and racial and ethnic minorities continue to develop type 2 diabetes at higher rates.

APAC is expected to grow at a higher CAGR of XX% in 2019.

Ongoing R&D activities, growing geriatric population, advancements in medical infrastructure, better healthcare facilities, rising cases of diabetes in the region are the factors owing to which the region is expected to witness lucrative growth. Moreover, the increase in the adoption of miniaturized device models which help reduce the time spent in hospitals or clinics is expected to surge the demand for glucose POC testing devices, making the Asia Pacific the quickest growing region.

The report also helps in understanding Global Point-of-Care Glucose Testing Market dynamics, structure by analyzing the market segments and project the Global Point-of-Care Glucose Testing Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Point-of-Care Glucose Testing Market make the report investor’s guide.
Scope of the Global Point-of-Care Glucose Testing Market:

Inquire before buying

Global Point-of-Care Glucose Testing Market3
Global Point-of-Care Glucose Testing Market, by Region:

• North America
• Europe
• South America
• MEA
• APAC
Key players operating in global Point-of-Care Glucose Testing Market:

• Roche Diabetes Care
• LifeScan IP Holdings, LLC.
• Abbott
• Ascensia Diabetes Care
• Trividia Health
• Nova Biomedical
• Acon Laboratories, Inc.
• Alere
• EKF Diagnostics
• F. Hoffmann-La Roche Ltd.
• Nipro
• Platinum Equity, LLC. (LifeScan, Inc.)
• Prodigy Diabetes Care, LLC
• i-STAT
• Accu-Chek Inform II

About Us:
Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

 

Share:

Keywords: point-of-care glucose testing market

Comments

Other related blogs

Global Digital Insurance Platform Market – Industry Analysis and Forecast (2019-2026)

By : Maximize Market Research Company

Global Digital Insurance Platform Market was valued US$ 89.06 Bn in 2019 and is estimated to reach U..


Global Viral Vector Manufacturing Market – Industry Analysis and Forecast (2019-2026)

By : Maximize Market Research Company

Global Viral Vector Manufacturing Market was valued US$ 384.82 Mn in 2019 and is expected to reach U..


Global Potassium Formate Market- Industry Analysis and Forecast (2019-2027)

By : Maximize Market Research Company

Global Potassium Formate Market was valued US$ XX Mn. in 2019 and is expected to reach US$ XX Mn. by..


Turner Syndrome Market-Industry Analysis and forecast 2019 – 2027

By : Maximize Market Research Company

Turner Syndrome Market size was valued nearly US$ XX Bn. in 2019 and the total revenue is expected t..